P.D. van Helden, E.G. Hoal/ Comparative Immunology, Microbiology and Infectious Diseases 36(2013)287-294 land and Northern malawi. clinical and ntal Immunology 2006: 146: 390-9. [571 Verver S, Warren RM, Beyers N, Richardson M, van der Spuy GD. [59] van der Spuy GD, Kremer K, N, Dunbar R. nerican Journal lade-specific path haracteristics. Tuberculosis of Respiratory and Critical Care Medicine 2005: 171: 1430-5 [58 Lalor MK, Ben-Smith A, Gorak-Stolinska P, Weir RE, Floyd S. Blitz [60 Rappuoli R, Aderem A A 2020 vision for vaccines against HIV tuber- R, et al. Population differences in immune responses to Bacill culosis and malaria. Nature 2011: 473: 463-9294 P.D. van Helden, E.G. Hoal / Comparative Immunology, Microbiology and Infectious Diseases 36 (2013) 287–294 vaccination in Southern England and Northern Malawi. Clinical and Experimental Immunology 2006;146:390–9. [57] Verver S, Warren RM, Beyers N, Richardson M, van der Spuy GD, Borgdorff MW, et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. American Journal of Respiratory and Critical Care Medicine 2005;171:1430–5. [58] Lalor MK, Ben-Smith A, Gorak-Stolinska P, Weir RE, Floyd S, Blitz R, et al. Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancy. Journal of Infectious Dis￾eases 2009;199:795–800. [59] van der Spuy GD, Kremer K, Ndabambi SL, Beyers N, Dunbar R, Marais BJ, et al. Changing Mycobacterium tuberculosis population highlights clade-specific pathogenic characteristics. Tuberculosis 2009;89:120–5. [60] Rappuoli R, Aderem A. A 2020 vision for vaccines against HIV tuber￾culosis and malaria. Nature 2011;473:463–9